Status:
COMPLETED
To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
35-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to learn more about how AZD1305 is handled by the body, i.e the absorption, distribution, metabolism and excretion of AZD1305.
Eligibility Criteria
Inclusion
- Healthy volunteers
- A body mass index (BMI=weight/height2) of 19 to 30 kg/m2
Exclusion
- Potassium outside normal reference values
- ECG findings outside normal range
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00689247
Start Date
April 1 2008
End Date
May 1 2008
Last Update
December 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Macclesfield, Cheshire, United Kingdom